Lucrin Depot 11.25 MG


Indications and Reactions:

Role Indications Reactions
Primary
Prostate Cancer 38.7%
Product Used For Unknown Indication 22.3%
Drug Use For Unknown Indication 10.4%
Breast Cancer 3.8%
Hypertension 3.1%
Pain 2.8%
Endometriosis 2.5%
Prophylaxis 2.2%
Gastric Disorder 1.9%
Anticoagulant Therapy 1.6%
Osteoporosis 1.6%
Oedema 1.3%
Panophthalmitis 1.3%
Benign Prostatic Hyperplasia 0.9%
Blood Cholesterol Increased 0.9%
Cataract Operation 0.9%
Constipation 0.9%
Hypercholesterolaemia 0.9%
Pollakiuria 0.9%
Prostate Cancer Metastatic 0.9%
Death 16.7%
Weight Increased 9.0%
Prostate Cancer 7.7%
Hospitalisation 6.4%
Emphysema 5.1%
Pulmonary Embolism 5.1%
Therapeutic Response Decreased 5.1%
Weight Decreased 5.1%
Contusion 3.8%
Disease Progression 3.8%
Malaise 3.8%
Oedema Peripheral 3.8%
Prostatic Specific Antigen Increased 3.8%
Staphylococcal Abscess 3.8%
Transient Ischaemic Attack 3.8%
Accident 2.6%
Angiopathy 2.6%
Diabetic Foot 2.6%
Erectile Dysfunction 2.6%
Haemorrhagic Stroke 2.6%
Secondary
Prostate Cancer 46.3%
Product Used For Unknown Indication 36.4%
Endometriosis 4.1%
Drug Use For Unknown Indication 3.3%
Prophylaxis 2.5%
Gastric Disorder 1.7%
Hypercholesterolaemia 1.7%
Hypertension 1.7%
Anticoagulant Therapy 0.8%
Back Pain 0.8%
Hot Flush 0.8%
Death 53.6%
Prostatic Specific Antigen Abnormal 14.3%
Renal Failure 14.3%
Injection Site Scar 3.6%
Lung Disorder 3.6%
Myocardial Infarction 3.6%
Rectal Haemorrhage 3.6%
Renal Cyst 3.6%

Drug Data